Nature at the AAAS

aaas brain.jpgNature operatives are still at the American Association for the Advancement of Science meeting in San Diego. Here’s a round up of their latest news, from our In the Field blog.

This is your brain on music

In one of the more astonishing demonstrations heard at Saturday’s music and language session, Northwestern University neuroscientist Nina Kraus started by playing the sound of someone saying the syllable ‘da’. …read more…

Blogs, twitter, videos … oh my!

It would have been more appropriate to have my laptop open and to blog or twitter while at the talk on Communicating Science in the New Information Age. But alas, even if I had remembered my laptop at 8:30 in the morning, it would have been useless at the San Diego Convention Center; oddly enough, most of the rooms lack WiFi. …read more…

13 months of science and Obama

You have to hand it to Eric Lander: he gives a good talk. At last night’s plenary session, he admitted he would have been more comfortable talking about the human genome. …read more…

Stem Cells, Quackery, Ratings

With stem cells the latest therapy to be abused by unscrupulous practitioners, a research society plans to help patients identify quackery. Come April, the International Society for Stem Cell Research is to launch a program to rate and approve stem cell therapy programs worldwide. …read more…

Different on the inside

They may look the same, and behave the same — but under the surface pluripotent stem cells are not the same. That was the message coming from a well-attended AAAS session this afternoon. …read more…

Six snippets from Francis Collins

His first six months as director of NIH have “been a wild ride”. …read more…

Data techs needed

Should every research group have a full time data-handler? I’m persuaded after hearing about the multiple pitfalls associated with handling scientific data in modern research. …read more…

Dust, Puffins, Iceland

A new trail to dust from receding Arctic glaciers began among a colony of Puffins on a small island off Iceland. …read more…

Image: photo by jepoirrier via Flickr under creative commons

Nature at the AAAS

aaas brain.jpgNature operatives are still at the American Association for the Advancement of Science meeting in San Diego. Here’s a round up of their latest news, from our In the Field blog.

This is your brain on music

In one of the more astonishing demonstrations heard at Saturday’s music and language session, Northwestern University neuroscientist Nina Kraus started by playing the sound of someone saying the syllable ‘da’. …read more…

Blogs, twitter, videos … oh my!

It would have been more appropriate to have my laptop open and to blog or twitter while at the talk on Communicating Science in the New Information Age. But alas, even if I had remembered my laptop at 8:30 in the morning, it would have been useless at the San Diego Convention Center; oddly enough, most of the rooms lack WiFi. …read more…

13 months of science and Obama

You have to hand it to Eric Lander: he gives a good talk. At last night’s plenary session, he admitted he would have been more comfortable talking about the human genome. …read more…

Stem Cells, Quackery, Ratings

With stem cells the latest therapy to be abused by unscrupulous practitioners, a research society plans to help patients identify quackery. Come April, the International Society for Stem Cell Research is to launch a program to rate and approve stem cell therapy programs worldwide. …read more…

Different on the inside

They may look the same, and behave the same — but under the surface pluripotent stem cells are not the same. That was the message coming from a well-attended AAAS session this afternoon. …read more…

Six snippets from Francis Collins

His first six months as director of NIH have “been a wild ride”. …read more…

Data techs needed

Should every research group have a full time data-handler? I’m persuaded after hearing about the multiple pitfalls associated with handling scientific data in modern research. …read more…

Dust, Puffins, Iceland

A new trail to dust from receding Arctic glaciers began among a colony of Puffins on a small island off Iceland. …read more…

Image: photo by jepoirrier via Flickr under creative commons

WHO fights claims H1N1 pandemic was hyped

flu.JPGAll Nature’s pandemic flu coverage is collected on our news special page.

The World Health Organization has again faced allegations that it has mishandled and overhyped the H1N1 outbreak.

Speakers at yesterday’s hearing of the Council of Europe’s Health Committee railed against the WHO’s declaration of a pandemic.

“The definition of a pandemic was changed by the WHO last May. It was only this change of definition which made it possible to transform a run-of-the-mill flu into a worldwide pandemic – and made it possible for the pharmaceutical industry to transform this opportunity into cash, under contracts which were mainly secret,” Wolfgang Wodarg, former chair of the Parliamentary Assembly of the Council of Europe’s sub-committee on health, told the hearing.

Ulrich Keil, director of the WHO Collaborating Centre for Epidemiology at the University of Munster, told the committee that “a number” of scientists were questioning the declaration of a pandemic.

“We are witnessing a gigantic misallocation of resources in terms of public health,” he said. “Governments and public health services are wasting huge amounts of money in investing in pandemic diseases whose evidence base is weak.”

While swine flu has not become the deadly global pandemic that some feared it has still caused at least 14,142 deaths according to the most recent WHO data and the WHO has strongly defended itself.

It sent Keiji Fukuda, a WHO special advisor on pandemic influenza, to the hearing. “The labelling of the pandemic as ‘fake’ is to ignore recent history and science and to trivialize the deaths of over 14 000 people and the many additional serious illnesses experienced by others,” he said.

Earlier this year Nature warned in an editorial that, “The danger now is that last year’s relatively mild pandemic will create a false sense of security and complacency. The reality is that next time we might not be so lucky — especially given that this time most of the world’s population, living as they do in developing countries, had no access to either vaccines or antiviral drugs.”

Ceci n’est pas une vaccine order

flu.JPGAll Nature’s pandemic flu coverage is collected on our news special page.

Pharma companies have been left fretting over sales of the H1N1 vaccine after France cancelled a huge chunk of its order for jabs.

The French health ministry announced on 4 January that it was terminating orders for 50 million of the 94 million doses initially ordered. Millions more doses are being sold to other countries including Qatar and Egypt.

Opposition parties in France are attempting to make political capital out of the issue, attacking French president Nicolas Sarkozy over his handling of vaccine ordering and claiming that pharma companies have been the major beneficiaries of the government’s actions.

Take up of H1N1 vaccination has been poor in many countries and initial fears that two doses would be needed to confer immunity have been easing recently. Other countries – including Germany, Spain and Switzerland – have also cancelled vaccine orders (Reuters). Share prices in pharma companies have not responded well to these pieces of news.

See also

WHO-led H1N1 vaccine redistribution may be scaled back as countries reassess need – Canadian Press

Sarkozy under fire on flu vaccine ‘fiasco’ – Financial Times

En Francais

Le gouvernement revoit sa stratégie antigrippe A – Le Monde

H1N1 : un coût de plus d’un milliard d’euros – Le Figaro

Grippe A : ne pas se tromper de débat – Yves Threard, Le Figaro

China frets over swine flu

flu.JPGAll Nature’s pandemic flu coverage is collected on our news special page.

China has confirmed that there have been 659 deaths from H1N1 in the country as of 2 January. In total, 120,940 cases of swine flu have been recorded, says the ministry of health.

“The danger of an explosion of outbreaks in some places exists, and the number of fatalities and serious cases will remain at a rather high level,” warned Liang Wannian, director of the ministry’s emergency response office (AFP).

Liang also warned of problems controlling the spread of H1N1, especially in rural areas. The problem may get worse as Chinese New Year approaches and many people travel around the country.

Last month the World Health Organization said that, as of 27 December 2009, over 200 countries have reported laboratory confirmed cases H1N1 and at least 12,220 deaths have been recorded.

Concern over Tamiflu-resistant H1N1 cluster in Vietnam

flu.JPGVietnamese health officials have reported a cluster of drug-resistant H1N1 cases.

In a paper published in the New England Journal of Medicine they report that 10 students travelled together on a 42-hour train journey in July this year and at least six of them later developed tamiflu-resistant swine flu. The paper notes that the students did not know each other before the train ride and had no contact with people suspected of H1N1 infection. Nor had any of them received tamiflu (oseltamivir).

“In this cluster, infection developed in at least 6 of the 10 people who were probably exposed to the index patient; this shows that resistant 2009 H1N1 viruses are transmissible and can replicate and cause illness in healthy people in the absence of selective drug pressure,” write the Vietnam H1N1 Investigation Team. “… The loss of oseltamivir as a treatment option for severe 2009 H1N1 infection could have profound consequences.”

Earlier this month the World Health Organization reported two clusters of patients infected with tamiflu-resistant H1N1, one in Wales and one in North Carolina. However both these incidents involved patients whose immune systems were already weakened and the virus was probably passed between patients in each group.

“This [the Vietnam outbreak] is different and it does raise the levels of concern. But it also I think reinforces the message that we do need to be constantly monitoring for this. And reporting it as quickly as it’s observed,” Charles Penn of the WHO told the Canadian Press.

All the patients in the Vietnamese case eventually recovered.

All Nature’s pandemic flu coverage is collected on our news special page.

Swine flu vaccine round up

flu.JPGAll Nature’s pandemic flu coverage is collected on our news special page.

It has been a mixed week for swine flu vaccines.

On Wednesday GSK announced use of one particular batch of its H1N1 jab should be halted after a higher than expected rate of severe allergic reactions related to the vaccine in Canada.

On the other hand, the US Centers for Disease Control and Prevention came out and backed the safety of vaccination. It says 22 million Americans have been vaccinated with 3,200 – mostly minor – side effects being reported.

“The vaccine data so far really suggests this is a safe vaccine,” said the CDC’s Anne Schuchat on Wednesday (AP).

In the UK David Salisbury, director of immunisation at the Department of Health, told family doctors to step up their vaccination efforts (Times). So far only 1 million of 10m distributed doses of vaccine have been used (Financial Times).

“Clearly I would have liked a bigger number, but that is what we have so far. I would like to see an acceleration now,” says Salisbury (BBC).

Some reports have indicated that doctors and pregnant women are wary of vaccination in the UK (Pulse).

Ireland is also pushing people to be vaccinated. “Children under five are a high priority group and . . . we are concerned that we are not getting a sufficient number of them vaccinated,” said Pat Doorley, national director of population health, on Friday (Irish Times).

The Oprah effect

jenny-mccarthy
Jenny McCarthy: vaccine expert

When it comes to swine flu vaccine, US health officials seem to be fearing fear itself.

Unlike most countries, the US is not using adjuvants in its swine flu vaccine. To do so, US health authorities must approve them in the vaccine on an ‘emergency’ basis. Why haven’t they?

One reason is that officials are concerned that people will reject the vaccine. That seems clear from recent congressional testimony by Anne Schuchat, head of immunization and respiratory diseases at the US Centers for Disease Control and Prevention.

Here is an exchange at a hearing last week between Schuchat and representative Bark Stupak:

Stupak: What is the problem with the adjuvant other than we haven’t done the test here in this country? [Referring to data obtained in Europe on the safety of the swine flu adjuvant]

Schuchat: Well, you know — as you know, the public’s confidence in our vaccine system and in vaccines in this country — very, very fragile.

Schuchat voiced similar concerns in an interview with Reuters. The decision surely was not easy for Shuchat and other health officials: if they had decided to use adjuvants, which reduce the dosage needed in a flu shot, the US would probably not be facing vaccine shortages—something I have blogged about before.

Other considerations, of course, factored into the decision. For instance, Jesse Goodman, an FDA official, told congress that the bulk of the safety data for the adjuvanted vaccine has been obtained in people over age 50, “So in terms of the kind of broad experience with millions of people that’s only in the elderly who were not a focus population of this vaccine…we don’t have enough data about those at this point or at the beginning of the pandemic for them to meet the standard of FDA licensure.”

Clearly, officials have the concerns and safety of the public in mind. It is also difficult to fault US agencies for considering the concerns of a public inundated with faulty information on vaccine safety, proliferating on the internet and aired by Don Imus, the Huffington Post and Oprah. Oprah, for instance, recently signed a deal with celebrity anti-vaccine activist Jenny McCarthy. The former playboy bunny is a regular guest on her show.

I wonder if Oprah has got her flu shot yet.

China cracks down on suspected H1N1 underreporting

flu.JPGPosted for David Cyranoski

The Chinese government has sent inspection teams to check on H1N1 reporting after a famed Chinese doctor accused local governments of covering up swine flu cases.

Zhong Nanshan of Guangzhou Institute of Respiratory Diseases in southern China, called into question the official number of deaths from H1N1, telling the Southern Metropolis Daily newspaper that the quoted figure of 53 was too low. “I just don’t believe that there have been 53 H1N1 deaths nationwide,” he said.

Yesterday Ministry of Health spokesman Deng Haihua, said any officials who do not carry out their H1N1 reporting duties or who delay reporting will be “held accountable”. He also said that teams had been sent to inspect pandemic control. In total nine groups have been sent to Hebei, Shanxi, Inner Mongolia, Liaoning, Jilin, Heilongjiang, Zhejiang, Hunan, Gansu, Qinghai, Ningxia, and Xinjiang (official statement).

While many have pointed out that limitations on testing capacity have led to an underreporting, Zhong suggested that some hospitals were intentionally not testing those who died from pneumonia for H1N1.

His words carry weight because he shot to fame during the Sudden Acute Respiratory Syndrome (SARS) outbreak in 2003 for quickly recognizing and reacting to the threat posed by the new virus while government officials around the country tried to cover it up.

All Nature’s pandemic flu coverage is collected on our news special page

The statins-for-flu study that the press missed

While researchers are calling for studies to evaluate the effectiveness of the cholesterol lowering drugs known as statins for reducing influenza-associated deaths, one such study is just getting underway, largely on volunteerism and shoestring funding.

Newspapers reported yesterday (e.g. here, here and here) from the 2009 Infectious Diseases Society of America meeting in Philadelphia that statin use appears to be associated with a lower death rate from influenza. Using data from the 2007-2008 flu season, researchers reviewed charts from 2,800 lab-confirmed influenza-associated hospitalizations. More than 800 of these individuals were taking statins at the time. Meredith VanderMeer of the Oregon Public Health Division and her colleagues found that 2.1% of patients taking statins died within a month of being hospitalized for the flu, while 3.2% who were not taking statins died.

Statins have been suggested before as a potential alternative to antiviral drugs like oseltamivir (Tamiflu) and zanamivir (Relenza), which are more expensive and have the potential to run out in a severe pandemic. Statins may reduce the effects of the virus by dampening the immune response.

Continue reading